Research is ongoing to determine whether TPO can serve as a useful biomarker for diagnosing and monitoring certain cancers. Elevated TPO levels have been observed in patients with various cancers, including ovarian cancer and breast cancer. However, the clinical utility of TPO as a biomarker in oncology is still under investigation, and further studies are needed to establish its diagnostic and prognostic value.
